340 related articles for article (PubMed ID: 21175573)
1. Development of radiotracers for oncology--the interface with pharmacology.
Sharma R; Aboagye E
Br J Pharmacol; 2011 Aug; 163(8):1565-85. PubMed ID: 21175573
[TBL] [Abstract][Full Text] [Related]
2. Current topics in the development of radioligands for positron-emission tomography imaging.
Horti AG; Dannals RF
Curr Top Med Chem; 2010; 10(16):1584. PubMed ID: 20868363
[No Abstract] [Full Text] [Related]
3. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
4. Radiopharmaceuticals for oncology drug development: a pharmaceutical industry perspective.
Murphy PS; Bergström M
Curr Pharm Des; 2009; 15(9):957-65. PubMed ID: 19275660
[TBL] [Abstract][Full Text] [Related]
5. Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.
Assmus F; Seelig A; Gobbi L; Borroni E; Glaentzlin P; Fischer H
Eur J Pharm Sci; 2015 Nov; 79():27-35. PubMed ID: 26341407
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic imaging in drug discovery.
Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive molecular imaging of beta-adrenoceptors in vivo: perspectives for PET-radioligands.
Kopka K; Law MP; Breyholz HJ; Faust A; Höltke C; Riemann B; Schober O; Schäfers M; Wagner S
Curr Med Chem; 2005; 12(18):2057-74. PubMed ID: 16101494
[TBL] [Abstract][Full Text] [Related]
8. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
9. "Mixed" anionic and non-ionic micellar liquid chromatography for high-speed radiometabolite analysis of positron emission tomography radioligands.
Nakao R; Halldin C
J Chromatogr A; 2013 Mar; 1281():54-9. PubMed ID: 23399000
[TBL] [Abstract][Full Text] [Related]
10. Design of new beta1-selective adrenoceptor ligands as potential radioligands for in vivo imaging.
Kopka K; Wagner S; Riemann B; Law MP; Puke C; Luthra SK; Pike VW; Wichter T; Schmitz W; Schober O; Schäfers M
Bioorg Med Chem; 2003 Aug; 11(16):3513-27. PubMed ID: 12878144
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET.
Brady F; Luthra SK; Brown GD; Osman S; Aboagye E; Saleem A; Price PM
Curr Pharm Des; 2001 Dec; 7(18):1863-92. PubMed ID: 11772355
[TBL] [Abstract][Full Text] [Related]
12. [Radiolabeled proteins for the development of biopharmaceuticals].
Harada R; Morito T; Yanai K
Nihon Yakurigaku Zasshi; 2020; 155(3):159-163. PubMed ID: 32378635
[TBL] [Abstract][Full Text] [Related]
13. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
Gomes PMO; Silva AMS; Silva VLM
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
[TBL] [Abstract][Full Text] [Related]
14. Gallium-68 and scandium-44 labelled radiotracers based on curcumin structure linked to bifunctional chelators: Synthesis and characterization of potential PET radiotracers.
Orteca G; Sinnes JP; Rubagotti S; Iori M; Capponi PC; Piel M; Rösch F; Ferrari E; Asti M
J Inorg Biochem; 2020 Mar; 204():110954. PubMed ID: 31838188
[TBL] [Abstract][Full Text] [Related]
15. Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2.
Kilbourn MR; Koeppe RA
ACS Chem Neurosci; 2019 Jan; 10(1):25-29. PubMed ID: 30198706
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.
Pantel AR; Mankoff DA
Cancer Lett; 2017 Feb; 387():25-31. PubMed ID: 27195912
[TBL] [Abstract][Full Text] [Related]
17. Advances in PET myocardial perfusion imaging: F-18 labeled tracers.
Rischpler C; Park MJ; Fung GS; Javadi M; Tsui BM; Higuchi T
Ann Nucl Med; 2012 Jan; 26(1):1-6. PubMed ID: 22069195
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography oncology research in the UK: a comparison with USA and Europe.
Fleming IN; Regel SJ; Pike LC; Marsden PK; Gilbert FJ
Nucl Med Commun; 2012 Apr; 33(4):341-8. PubMed ID: 22367857
[TBL] [Abstract][Full Text] [Related]
19. PET of signal transduction pathways in cancer.
Holland JP; Cumming P; Vasdev N
J Nucl Med; 2012 Sep; 53(9):1333-6. PubMed ID: 22879078
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography for use in microdosing studies.
Wagner CC; Müller M; Lappin G; Langer O
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
